Antisense and RNAi Therapeutics Market Size, Share, Growth Drivers, Opportunities, Share, Competitive Analysis and Forecast to 2030
Antisense and RNAi Therapeutics Market Overview: Antisense and RNAi therapeutics are a class of drugs that target RNA molecules to treat various diseases. The global Antisense and RNAi Therapeutics market was valued at US$ 1,284.2 million in 2023 and is anticipated to reach US$ 1,881.9 million by 2030, with a CAGR of 5.5% during the forecast period (2024-2030). Get An Exclusive Sample of The...
0 Comentários 0 Compartilhamentos 770 Visualizações 0 Anterior